Alberto Giovanni Leone shared updated results of the INFINITY trial—which evaluates the combination treatment of tremelimumab and durvalu...

x.com· @ · X·2026-04-23 02:32· 2026-04-23Score60

Body

Alberto Giovanni Leone shared updated results of the INFINITY trial—which evaluates the combination treatment of tremelimumab and durvalumab—on Tuesday at #AACR26. Learn more in AACR Annual Meeting News: https://t.co/bqUiZhEegV https://t.co/71VjEhfL1J

Heat 15 · 7 likes · 1 reply · 7 reposts

Conference abstracts

6547NCT06526104matched by 药名 durvalumab

Phase II single arm study of tremelimumab and durvalumab (MEDI4736) (T300+D) in advanced hepatocellular carcinomas with Child-Pugh-B cirrhosis (STRIDE in CP-B)

Sukeshi Patel Arora, Lorena Fuentes, James Denno, Jennifer Moseley, Brittany M. Altermatt, Elizabeth Diaz, Joshua Ray Smith, Joel Michalek, Lei Zheng

Read the abstract →

CT230NCT04817826matched by 药名 tremelimumab

STRIDE regimen of tremelimumab and durvalumab as non-operative management strategy of microsatellite instability-high (MSI-H) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC): Final results of the cohort 2 of INFINITY study by GONO GI

Alberto Giovanni Leone, Alessandra Raimondi, Paolo Manca, Sabina Murgioni, Giovanni G. Cardellino, Alessandro Bittoni, Antonia Strippoli, Maria Bencivenga, Federica Palermo, Floriana Nappo, Silvio K. Garattini, Thereasa Rich, Gaia Rebecchi, Roberta Fazio, Camilla Damonte, Margherita Ambrosini, Cecilia Villa, Greta Gronchi, Sara Lonardi, Filippo Pietrantonio

Read the abstract →

Source: x.com · x.com